long intergenic non-protein coding RNA 2370Genealiases: []
Q-omics provides the consensus-scored LINC02370 profile across patient tissues and cancer cell-line models. LINC02370 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02370 is differentially expressed in 4, with the highest sampling consensus in UCEC. Additionally, LINC02370 RNA expression shows 6,651 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KICH, UCEC, and TGCT as cancer lineages where LINC02370 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02370 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02370 survival associations across molecular data types. LINC02370 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02370 RNA expression–survival associations across cancer types. High LINC02370 expression shows unfavorable associations in KICH, LIHC, ACC, KIRC and BLCA, but favorable associations in UCEC. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02370 RNA expression.
This table summarizes LINC02370 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in UCEC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02370. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02370 shows lower tumor expression in UCEC, ESCA and STAD and higher tumor expression in KIRC. The UCEC box plot shows higher LINC02370 RNA expression in normal versus tumor tissue (log2 FC = −0.380, t-test p < 0.001).
This table shows molecular features associated with LINC02370 in patient tissues and cancer cell lines. In patient samples, LINC02370 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
